With one exception, everything YouTube banned from us was good and meaningful information that’s never been debunked, or legit skepticism and inquiry. This interview should be no exception. Besides the shocking “coincidences” with current events.
They deleted it before I even had the chance to edit the title đ
The full text of my appeal to YouTube’s ban:
We all know you have no competence, capability, grounds or rights to do what you are claiming to do, and, in fact, you’re deleting stuff because it exposes your own business. But an YouTube ban brings me more traffic than I lose on your crappy narrative-enforcement machine, so keep up the great work! đ
January 2014 interview with Anthony Patch, founder of Entangled Magazine an insightful and revelatory digital publication focused on current advances and pronouncements in: Quantum Computing, Artificial Intelligence, Cryptocurrencies/Blockchain, Quantum Mechanics, DNA/RNA Modification.
His YouTube channel has also been deleted, but he’s active on Bitchute.
I can’t vouch for some of the things he (or anyone) is saying on his channel, but smart people have a lot to learn from what he puts out. Other than that, see our motto in the website header đ
We are funded solely by our most generous readers and we want to keep this way. Help SILVIEW.media deliver more, better, faster, please donate here, anything helps. Thank you!
! Articles can always be subject of later editing as a way of perfecting them
Now THESE are words I never imagined I would ever write. And these are the times…
So I am here to praise rapper Pitbull. Not only for wokeness and having the balls to drop truth bombs, not only for being informed…
But mainly because he struck a major chord, with his plead for freedom. You see, I am too born and raised in the communist gulag, my Romania and his Cuba were very much alike back then, 30+ years ago… So after seeing this, I REALLY REALLY WANT TO GIVE A HUG TO THIS MAN, you know, make it physical. I also feel bad, I lumped him with the Cardi B’s of this world, and that’s his fault for making money with all these sell outs. But then again, if he keeps dropping truth from that height, it’s all better than good. So watch this and please please spread it around, it has the potential to drive more awareness in the masses! Let’s end this shit!
PS: The part where he says Fidel Castro must be dead jealous on Klaus Schwab… đ„đ„đ„
Watch the whole show and tell them Silview sent you over, for the woke part (it’s over 2h long) đ
We are funded solely by our most generous readers and we want to keep this way. Help SILVIEW.media deliver more, better, faster, please donate here, anything helps. Thank you!
! Articles can always be subject of later editing as a way of perfecting them
Can’t wait for to label this video below as “Censored by Youtube” and cash in on the Streissand effect, which has already given massive headaches to the Silicon Sillies, and they still haven’t learned. But that’s besides the main point below.
ANALYSIS
Censorship is a primitive moronic concept which you can’t materialize against 7+ billion people with man-power alone, you need artificial help, like AI’s
Most BigTech dipshits have inherited their fortunes and merits, and are too stupid to understand AI’s aren’t really intelligent, it’s still just extreme computational power, a deep-fake of intelligence. Which is still stupid AF, despite some advantages, it’s Absent Intelligence. And the few who understand this also sell AI’s to morons like Klaus Schwab, to play their delusional megalomaniac real life Worlds of Warcraft on them. They’ve been duped same way they dupe others. Yeah, they’re great for stealing data and making models, but all AIs can be cancelled by a second of inspiration or brilliance from one living intelligence (this excludes those drones with bones that pass as people today, true).
Censorship is a form of lying through forced omission. Lies are like cancer: they either devour the host and get fucked with it, or they get eliminated. So the cancer approach is primitive and dumb too. The catch is that technology actually makes it harder to hide or enforce a lie, despite the elite’s beliefs. Maintaining a technological advance can’t compensate because that illicit advance also depends on maintaining some lies, not the other way around. Whichever way you may look at it, censorship is self-cannibalistic and the age of censorship is not starting, it’s behind, only RTRD DPSHTS like Klaus and Biden are still clinging on it.
When I was on the fence, censorship persuaded me that 9/11 was a hoax
quick DEMONSTRATION that still works (longer, better version soon, stay tuned)
Between Silview and Susan, she will regret her acts of censorship more, that’s already arranged
Some argue the soundtrack is the best part of this video, I say the info is even better if you pay real attention. Either way, word is out, please help the experiment by sharing this article or the video, thanks!
We are funded solely by our most generous readers and we want to keep this way. Help SILVIEW.media deliver more, better, faster, please donate here, anything helps. Thank you!
! Articles can always be subject of later editing as a way of perfecting them
Imagine sheep can be used to store information or mine Bitcoin. Then imagine what sheeple can do.
UPDATE: Whoa boy! CBS’ 60 minutes confirms the rule: SILVIEW.media is a glimpse in the future and a peak in the past, and mainstream media will run shabby versions of our headlines a few weeks or months after we got over them. Consider this an addendum to our work:
US intelligence officials say Chinese government is collecting Americans DNA via Covid tests – CBS
When Klaus Schwab cries about Dark Winters and cyber attacks, that’s the bait and biohacking is the switch. Most essential and chilling documentary to enter the Great Reset era. Unfortunately I can’t upload it on YouTube and embed it in this post because covidiots allowed a buncha psychopaths to rob us of our self-determination and free speech, installing this fucked up global fascist-techno-communist regime. Fortunately we still can take advantage of the last remnants of Internet freedom and you can watch it on a few free-speech platforms: Lbrary Bitchute(lower resolution) Brighteon more to be added (hopefully)
This is the third and final part on the Biohacking trilogy I promised and delivered. Being final doesn’t mean it’s finished, looks like it’s going to be ever growing and updated, so if you come back to these posts in a few months, you might observe significant updates.
More links, resources and comments to be added here soon, right now I’m exhausted, but anxious to get this in front of you, I invested myself quite a lot in it, enjoy!
We are funded solely by our most generous readers and we want to keep this way. Help SILVIEW.media deliver more, better, faster, please donate here, anything helps. Thank you!
! Articles can always be subject of later editing as a way of perfecting them
HSBC is a Chinese bank and……HSBC is also involved with Dominion voting, among others…
We are funded solely by our most generous readers and we want to keep this way. Help SILVIEW.media deliver more, better, faster, please donate here, anything helps. Thank you!
! Articles can always be subject of later editing as a way of perfecting them
UK’s Government’s Medicines & Healthcare products Regulatory Agency (MHRA) spends close to $2million on an Artificial Intelligence to monitor “Medicines & Healthcare products Regulatory Agency”. If this isn’t alarming, I don’t know what is. But I know there’s more to the story.
The MHRA urgently seeks an Artificial Intelligence (AI) software tool to process the expected high volume of Covid-19 vaccine Adverse Drug Reaction (ADRs) and ensure that no details from the ADRsâ reaction text are missed.
The acquisition document further provides this explanation:
“For reasons of extreme urgency under Regulation 32(2)(c) related to the release of a Covid-19 vaccine MHRA have accelerated the sourcing and implementation of a vaccine specific AI tool.
Strictly necessary â it is not possible to retrofit the MHRAâs legacy systems to handle the volume of ADRs that will be generated by a Covid-19 vaccine. Therefore, if the MHRA does not implement the AI tool, it will be unable to process these ADRs effectively. This will hinder its ability to rapidly identify any potential safety issues with the Covid-19 vaccine and represents a direct threat to patient life and public health.
Reasons of extreme urgency â the MHRA recognises that its planned procurement process for the SafetyConnect programme, including the AI tool, would not have concluded by vaccine launch. Leading to a inability to effectively monitor adverse reactions to a Covid-19 vaccine.
Events unforeseeable â the Covid-19 crisis is novel and developments in the search of a Covid-19 vaccine have not followed any predictable pattern so far.”
Beneficiary of this contract is a company named Genpact, part of a larger multi-industry group with the same name. Genpact also does Facebook moderation, which gives it access to Facebook data!
Genpact CEO is close to our old friends from WEF, of course
According to a new @wef Future of Jobs Report, 50% of employees will require reskilling by 2025. Retraining employees at scale not only works, but is cost-effective and serves clientsâ interests: https://t.co/Yt9lnpIGbk#Reskilling#FutureofWork
He seems to applaud a Biden victory in the US presidentials. :
âItâs easier to be a parent this morning. Itâs easier to be a dad. Itâs easier to tell your kids character matters. It matters. Tell them the truth matters."
This Tyger dude basically has all the traits and inclinations of the elite mafia that set up Covidiocracy as the new business and live-stock management model for the whole world.
Genpact has acquired 23 companies, including 10 in the last 5 years. A total of 8 acquisitions came from private equity firms. Genpactâs largest acquisition to date was in 2011, when it acquired Headstrong for $550M. Genpact has acquired in 11 different US states, and 5 countries. The Companyâs most targeted sectors include information technology (28%) and software (28%). – Mergr
Gentec CEO interview
We are funded solely by our most generous readers and we want to keep this way. Help SILVIEW.media deliver more, better, faster, please donate here, anything helps. Thank you!
! Articles can always be subject of later editing as a way of perfecting them
This life-changing information has been sitting on UK Government’s website for over 15 months now. People find out about it from us, while their officials keep yapping 24/7 about an infection we can’t test for and a virus that’s never been properly isolated and purified in a lab as per Koch’s Postulate. Of course, this plan is not limited to UK, it’s global. Looks like democracy is as real as Rona, your informed consent matters and governments care.
The Fourth Industrial Revolution is not a buzzword, it’s official policy in every state controlled by the World Bank /IMF / Rothschild dynasty. It’s been so for long now. And The Great Reset gives you the map for it, in that Technocrat language that is translated to functional-illiterate sheeple as whatever they need to hear to stay obedient, while the sheeple-herders get actual live-stock management advice.
Policy paper
Regulation for the Fourth Industrial Revolution
Published 11 June 2019
Presented to Parliament by the Secretary of State for Business, Energy and Industrial Strategy by Command of Her Majesty
Excerpts selected by Silview.media, read the whole thing please!
Foreword
The world is changing faster than ever. New technology is creating new industries, changing existing ones and transforming the way things are made. We need a more agile approach to regulation, that supports innovation while protecting citizens and the environment.
We are a nation of innovators. Throughout our history we have seized the opportunities to create a better future for ourselves. In the First Industrial Revolution, British engineer Thomas Saveryâs pump paved the way for industrial use of steam power. In the second, British scientist Michael Faradayâs electromagnetic rotary devices formed the basis for practical electricity use. In the third, British computer scientist Tim Berners-Lee invented the world wide web.
Technological breakthroughs in areas from artificial intelligence to biotechnologies are now heralding a Fourth Industrial Revolution, with the power to reshape almost every sector in every country. Our Industrial Strategy positions the UK to make the most of this global transformation.
Our regulatory system is second to none, as recognised by the Organisation for Economic Cooperation and Developmentâs Regulatory Policy Outlook in 2018. It protects citizens and enables business to thrive. Together with our global research prowess, world-class universities and open, competitive markets, it attracts firms to innovate and invest in the UK. As the Fourth Industrial Revolution changes the way we live and work, it is vital that our regulatory system keeps pace.
This white paper sets out our plan to maintain our world-leading regulatory system in this period of rapid technological change. We will support and stimulate new products, services and business models, with greater space for experimentation. We will uphold safeguards for people and the environment and engage the public in how innovation is regulated. And we will maintain the stable, proportionate regulatory approach the UK is rightly known for.
Our openness to technology and innovation continues as we leave the European Union.
This white paper is our plan to secure our success.
Rt Hon Greg Clark MP Secretary of State for Business, Energy and Industrial Strategy
Championing innovation
We need to take action to maintain our world-beating regulatory system and realise the potential of the Fourth Industrial Revolution.
The Fourth Industrial Revolution
The Fourth Industrial Revolution is of a scale, speed and complexity that is unprecedented. It is characterised by a fusion of technologies â such as artificial intelligence, gene editing and advanced robotics â that is blurring the lines between the physical, digital and biological worlds. It will disrupt nearly every industry in every country, creating new opportunities and challenges for people, places and businesses to which we must respond.
Our modern Industrial Strategy seeks to put the UK at the crest of this global wave of technological innovation, bringing the benefits to business and consumers alike. Our foundations are strong. The UK ranks in the top 5 in the Global Innovation Index1. We are a global leader in science and research and home to 4 of the top 10 universities in the world2. We have a thriving start-up environment and are home to many of the worldâs most R&D-intensive businesses. We develop and attract some of the most talented people in the world.
We want to build on our strengths in developing and deploying ideas to become the worldâs most innovative economy. We want to raise our total investment in R&D to 2.4% of GDP by 2027, the biggest increase on record. We have set 4 Grand Challenges for the UK government and wider economy to seize the opportunities presented by the Fourth Industrial Revolution.
The Industrial Strategy Grand Challenges
We will put the UK at the forefront of the artificial intelligence and data revolution.
We will maximise the advantages for UK industry of the shift to clean growth.
We will become a world leader in shaping the future of mobility.
We will harness the power of innovation to help meet the needs of an ageing society.
Our regulatory system is a national asset. We are ranked 9th among 190 economies for the ease of doing business in the UK3, with the quality of our regulatory practices given the highest overall country score by the Organisation for Economic Co-operation and Development (OECD)4. We protect the natural environment and ensure the safety and employment rights of citizens. We also provide the certainty needed for businesses to thrive.
The Fourth Industrial Revolution presents challenges for regulatory systems across the globe, as they struggle to keep pace with rapid, complex technological innovation. In our Industrial Strategy, we committed to develop an agile regulatory approach that supports innovation and protects citizens and the environment. We need to act now to maintain our world-beating regulatory system in this period of transformational change.
regulations
We need to reshape our regulatory approach so that it supports and stimulates innovation that benefits citizens and the economy. At present, only 29% of businesses believe that the governmentâs approach to regulation facilitates innovative products and services being efficiently brought to market 9. The need for reform is urgent: 92% of businesses from a range of sectors think they will feel a negative impact if regulators donât evolve to keep pace with disruptive change in the next 2 to 3 years10.
Other countries are rapidly reforming their regulatory environments to support future innovation, with Nesta describing these anticipatory approaches as âan increasingly important source of competitive advantage in the global economyâ11. By taking an anticipatory approach we can give people faster access to innovations that can transform their lives and attract the ideas, talent and investment to the UK that will drive our future prosperity.
We are turning things round. The Financial Conduct Authorityâs regulatory sandbox has kick-started a wave of regulator-led initiatives to support new products and services to come to market and been widely emulated across the globe. Our Regulatorsâ Pioneer Fund is accelerating the change, with ÂŁ10 million invested in 15 projects to support technologies from autonomous shipping to virtual lawyers. We have established a partnership with the World Economic Forum to shape the global governance of technological innovation.
we need to be on the front foot in reforming regulation in response to technological innovation
we need to ensure that our regulatory system is sufficiently flexible and outcomes-focused to enable innovation to thrive
we need to enableâŻgreater experimentation, testing and trialling of innovations under regulatory supervision
we need to support innovators to navigate the regulatory landscapeâŻand comply with regulation
we need to build dialogue with society and industry on how technological innovation should be regulated
we need to work with partners across the globe to reduce regulatory barriers to trade in innovative products and services
This white paper sets out our plan to tackle these 6 challenges and seize the opportunity presented by the Fourth Industrial Revolution. We want to lead the world in innovation-friendly regulation that supports the emergence of new products, services and business models for the benefit of all. The white paper will be matched later this year with papers describing how we will modernise consumer and competition regulation in response to the transformation in our economy.
Supporting the emergence of smart systems
Our energy system is changing rapidly. There is more low carbon generation, such as power from solar and wind, which produces different amounts of electricity depending on the weather. It is increasingly decentralised, with generation and batteries located in or near peopleâs homes and businesses. â New technologies such as electricity storage, smart heating controls and electric vehicles are emerging which can be used to help balance the electricity system. However, our regulatory system was not developed with these new technologies in mind.â
As laid out in the Smart Systems and Flexibility Plan, developed jointly with the energy regulator Ofgem, we are working to develop a best in class regulatory framework that supports these innovations. We are working with industry to reform markets, legislation, licences, codes and standards.
The drive towards a smart and flexible energy system is an important tenet of the governmentâs Clean Growth and Industrial Strategies. The changes promise to provide significant public benefits, from lower energy bills to cleaner air and lower carbon emissions. By 2050, a smarter and more flexible system could save the UK ÂŁ17-40 billion.
Accelerating the introduction of self-driving vehicles
The Centre for Connected and Autonomous Vehicles (CCAV) is overseeing a groundbreaking programme to prepare the UKâs regulatory framework for self-driving vehicles ahead of their introduction on UK roads. It has developed an open regulatory approach that safeguards citizens and supports the development of the technology as it evolves.
This includes the recently updated world-leading Code of Practice for testing automated vehicles. Testing any level of automated vehicles on public roads is possible, provided they comply with the law, including having a driver, in or out of the vehicle, a roadworthy vehicle, and appropriate insurance. The recent update to the Code announced that the government would introduce an application process for more advanced trials. This will facilitate the development of the technology, without the need for repeated changes to regulation.
CCAV is leading the charge in considering the wider implications of the introduction of self-driving vehicles. It has introduced legislation to insure the use of self-driving vehicles through the Automated and Electric Vehicles Act 2018, so that victims of collisions get quick and easy access to compensation. It has asked the Law Commission of England and Wales and the Scottish Law Commission to undertake a joint regulatory review to identify further legal obstacles to the widespread introduction of self-driving vehicles. This project is consulting widely and will provide a final report in 2021.
CCAV is also working with the British Standards Institution to deliver a programme of standards to help accelerate development and deployment of self-driving vehicles. The programme seeks to address public safety and reliability concerns and supports the UKâs reputation as a centre of excellence for vehicle testing, design and manufacturing.
CCAVâs programme has helped to put the UK at the forefront of this emerging industry and, with the Department for Transport, given the UK lasting influence in international debates on the regulation of automated vehicles.
Our plan
We will create an outcome-focused, flexible regulatory system that enables innovation to thrive while protecting citizens and the environment. We will match this with clarity for business through better use of regulatory guidance, codes of practice and industry standards.
We will pilot an innovation test so that the impact of legislation on innovation is considered as we:
develop and assess policy options
consult and engage on policy proposals
design, introduce and implement legislation
monitor, evaluate and review legislation
We will encourage policymakers to consider the governance of innovation in a holistic way, noting the role that alternatives to regulation can play in providing government, citizens and businesses with assurance. We will encourage policymakers to reflect on when the right time is to introduce regulation21 .
Our approach will encourage policymakers to focus on real-world outcomes, with legislation that provides flexibility for experimentation and adaptation. Prescriptive regulatory requirements would only be set out in legislation where necessary to provide important protections. Where possible, alternative approaches such as statutory guidance will set out requirements so that as technology changes the system can respond in a timely and flexible manner.
We will develop tools for policymakers to support them to consider these issues; we will also develop improved analytical methods to capture the impact of regulation on innovation. During the pilot, we will invite the Regulatory Policy Committee to scrutinise the application of the innovation test, to ensure that innovators have confidence in how government is developing significant new regulatory legislation.
Making the UK the safest place in the world to be online
The internet is a powerful force for good. Combined with new technologies such as artificial intelligence, it is changing society perhaps more than any previous technological revolution â growing the economy, making us more productive, and raising living standards.
Alongside these new opportunities come new challenges and risks. The internet can be used to spread terrorist material; it can be a tool for abuse and bullying; and it can be used to undermine civil discourse, objective news and intellectual property. As set out in our Digital Charter, we are committed to making the UK both the safest place to be online and the best place to start and grow a digital business.
In April, the Department for Digital, Culture, Media and Sport and the Home Office published a white paper to tackle a range of both legal and illegal harms, from cyberbullying to online child sexual exploitation. In keeping with our ambition to lead the world in innovation-friendly regulation that encourages the tech sector and provides stability for businesses, the white paper sets out an outcomes-focused legislative approach that will support future technological change.
From AI to blockchain, data-driven financial technologies (FinTech) are changing the way that we bank, invest, insure and even pay for things. The UKâs FinTech sector is booming, underpinned by our world-leading financial services sector and thriving tech scene.
In 2016, the Financial Conduct Authority seized the initiative to support this emerging industry by establishing the worldâs first âregulatory sandboxâ: a safe space where firms can work with the regulator to trial innovative products, services and business models with consumers without having to meet all the usual requirements for compliance. Since its establishment, the sandbox has received more than 3 times as many applications than places available. Access to the sandbox has helped reduce the time and cost of getting innovative ideas to market (in the first year, 90% of firms progressed towards wider market launch) and improve access to finance (40% received investment during or following their sandbox tests).
FinTech firm Asset Hedge introduced a web-based platform offering forex options to assist small businesses and individuals to protect against losses incurred because of currency fluctuations. They successfully completed the sandbox programme to become a fully regulated company. Assure Hedge founder and chief executive Barry McCarthy said:
âWe have effectively been given the same regulation that large banks have, so it really allows us to compete with the big players.â
Itâs not just business that benefits. Consumers benefit from new products which have better safeguards built in up front, while the regulator benefits from greater insight into technological innovation. The model has been emulated by more than 20 countries across the globe and translated to sectors from health to transport.
From smart shipping to AI-powered legal services
The Regulatorsâ Pioneer Fund is backing the Future of Mobility and AI and Data Grand Challenges through ground breaking projects to enable technologies from smart shipping to AI-powered legal services.
The Solicitors Regulation Authority has already taken steps to facilitate innovation in the legal industry, inviting firms to develop new business models in a controlled way. The Regulatorsâ Pioneer Fund investment will enable the Solicitors Regulation Authority to work with the innovation foundation Nesta to accelerate ethical AI-powered innovations, with a focus on legal services for small businesses and consumers where AI and automation can have transformative impact.
Paul Philip, Chief Executive of the Solicitors Regulation Authority, said:
âSmart use of technology could help tackle the problem that far too many people struggle to access expert legal advice. It will help us further build on our work to encourage new ways of delivering legal services, benefiting both the public and small business.â
In the Maritime and Coastguard Agency, the Regulatorsâ Pioneer Fund investment will create the Maritime Autonomy Regulation Lab (MAR Lab) to bring together industry specialists, academics and government to pioneer new regulatory approaches and make data available to the emerging smart shipping industry.
The project will inform UK legislation for a domestic framework for autonomous vessels to attract international business and support and promote testing in the UKâs territorial waters. It will also support government efforts to establish a new proactive and adaptive international regulatory framework for autonomous vessels at the International Maritime Organisation.
New discoveries and the application of new technologies mean we can diagnose illnesses earlier and more accurately, create new treatments and ensure existing ones are more effective.
The UK is extraordinarily well placed to play a leading role in this revolution in the life sciences, with strengths in innovation, research, healthcare and business. To support these innovations to come to market, the Medicines and Healthcare Products Regulatory Agencyâs (MHRA) Innovation Office provides a single point of access to regulatory advice on the development of innovative medicines, medical devices or manufacturing processes. The service has grown in popularity since its inception in 2013, receiving 190 enquiries in 2018.
The service helps to make regulatory information clear and accessible to those who are working on innovative research, supporting a key goal in the second Life Sciences Sector Deal to ensure the UK remains one of the best places in the world to develop life sciences projects, to protect health and improve lives.
The service has helped secure significant investments into the UK life sciences industry. John Parker, Director at AstraZeneca said:
âWe genuinely believe that having easy access to MHRA in this manner provides a real competitive advantage to UK based companiesâ
In the Life Sciences Sector Deal, the MHRA committed to engage with industry to understand how it can further develop its offer by the end of 2019.
Our plan
Entrepreneurs and innovative firms should be able to find their way through the UKâs regulatory landscape with ease and receive timely, joined-up feedback on novel propositions.
We will consult on a digital Regulation Navigator for businesses to help them find their way through the regulatory landscape and engage with the right regulators at the right time on their proposals. We will ensure that this is integrated with action to enhance the governmentâs digital offer to business in areas such as tax, grants, trade and investment, and build awareness of the available offer.
Initiatives such as the Financial Conduct Authorityâs regulatory sandbox have helped reduce the time and cost of bringing new products and services to market and enabled businesses to win contracts and secure access to finance. We are funding greater investment in specialist regulatory advice services for innovators through our Regulatorsâ Pioneer Fund, to ensure that innovators who are developing novel proposals with potential for wider economic, societal or environmental benefit are supported to do so.
Leading the public dialogue on mitochondrial replacement treatment
Mitochondria are present in almost all human cells and generate the majority of their energy supply. Unhealthy mitochondria can cause genetic disorders known as mitochondrial disease, which can have devastating effects on the families that carry them. For many patients with mitochondrial diseases, preventing the transmission of the disease to their children is a key concern.
In 2012, the Human Fertilisation and Embryology Authority undertook a sustained engagement programme to determine public acceptability of the use of mitochondrial replacement treatment, characterised in the media as â3 parent babiesâ. The programme included a breadth of engagement tools, including workshops, a public survey, open meetings and focus groups. It invited trusted scientific figures to take part in the debate.
The regulator found that despite certain ethical concerns there was general support for permitting mitochondria replacement in the UK, so long as it is safe enough to offer in a treatment setting and is done so within a regulatory framework. Following legislation, in 2017 the UK became the first country in the world to license mitochondrial donation techniques to allow women who carry the risk of serious mitochondrial disease to avoid passing it onto their children.
Our plan
We want innovators and the public to have confidence in the UKâs regulatory regime. We will build dialogue with society and industry on how technological innovation should be regulated.
We will ask the Regulatory Horizons Council to identify priorities for greater public engagement on regulation of innovation. For example, where technologies pose complex ethical or moral considerations greater public engagement may be appropriate to shape government thinking on appropriate regulatory frameworks. Government departments and regulators will continue to lead public engagement on their policies, working with expert bodies such as the Centre for Data Ethics and Innovation.
As part of its role, the Better Regulation Executive will provide support, advice and share best practice with policymakers and regulators on public engagement techniques to support appropriate regulation of technological innovation, working with partners such as Sciencewise. The Better Regulation Executive will build capability in novel and creative public engagement techniques that go beyond public consultation in this important area.
Engaging the public on regulation of drones
Drone technology is advancing rapidly with the potential to perform critical services in everyday life â from transporting urgent medical supplies to bridge inspection and repair. UK cities and regions need to consider what they want the future of drone applications to look like. PwC estimates that by 2030 drone use could increase UK GDP by ÂŁ42 billion.
With support from the governmentâs Industrial Strategy Challenge Fund, the innovation foundation Nesta funded public use analysis of drones in 5 cities for activities from inspecting burning buildings to traffic incident response. It worked with the government and the Civil Aviation Authority and convened local stakeholders to assess demand and identified the technical, economic and regulatory success factors for safe drone deployment at scale in cities.
The programme has concluded that there is demand for drones, which can fulfil socially beneficial goals. However, there are regulatory challenges that need to be solved â from how to deploy drones over long distances to what is publicly acceptable in terms of noise, privacy, safety and other issues. These issues are being considered as part of the Department for Transportâs Aviation Strategy 2050 green paper, looking at how a flexible regulatory framework can be established to support transport innovation under the Future of Mobility Grand Challenge and beyond.
.
Credit: Innovate UK
Setting global standards on smart cities
Many cities face challenges in ensuring sustainable growth, with issues ranging from provision of water and energy to management of healthcare and transport. A range of innovation is emerging to create the smart cities of the future.
The British Standards Institution has developed a ground-breaking series of standards on smart cities, in collaboration with the Future Cities Catapult. International recognition of the smart cities standards programme contributes to the UKâs reputation in advanced urban services and helps shape the global market in line with established UK good practice.
Downloaded in over 60 countries, UK smart city standards are being adopted as international standards. In China, the worldâs largest smart cities market, the British Standards Institution has set up a cooperation agreement on smart cities with the Standards Administration of China to develop a common approach to smart cities between UK and Chinese cities and companies.
Conclusion
This white paper is our long-term strategy for maintaining our world-leading regulatory environment as we enter the Fourth Industrial Revolution. The Ministerial Working Group on Future Regulation will drive its delivery, supported by the Better Regulation Executive.
The white paper is a plan for the whole of government, shaping how we will regulate in areas from healthcare to transport. We want to give businesses confidence to innovate and invest in the UK and give citizens confidence in our protections.
In addressing these issues we respect the devolution settlements with Scotland, Wales and Northern Ireland. We will work with our partners in the devolved administrations and local authorities to share our innovation-enabling approach and ensure that every part of the UK benefits from the Fourth Industrial Revolution.
Summary of commitments
Facing the future
We will establish a Regulatory Horizons Council to identify the implications of technological innovation and advise the government on regulatory reform needed to support its rapid and safe introduction.
The Council will prepare a regular report on innovation across the economy, with recommendations on priorities for regulatory reform to put the UK at the forefront of the industries of the future.
The Ministerial Working Group on Future Regulation, chaired by the Business Secretary, will oversee the government response to the Councilâs recommendations.
Focusing on outcomes
We will pilot an innovation test so that the impact of legislation on innovation is considered during the development of policy, introduction and implementation of legislation and its evaluation and review.
During the pilot, we will invite the Regulatory Policy Committee to scrutinise the application of the innovation test, to ensure that innovators have confidence in how government is developing new legislation.
We will promote new ways to trigger when post-implementation reviews of legislation are undertaken to ensure that legislation does not inadvertently âlock inâ outdated technologies or approaches.
We will develop tools for regulators to support them to review their guidance, codes of practice and other regulatory mechanisms to ensure that they provide flexibility for those businesses that want to innovate, while ensuring a clear route to compliance.
We will support business, policymakers and regulators to make effective use of standards where appropriate as a complement to legislation.
We will invite the Office for Product Safety and Standards, British Standards Institution, National Physical Laboratory and UK Accreditation Service to set out their vision for how the development and review of standards should evolve as we enter the Fourth Industrial Revolution.
Supporting experimentation
We will examine the case for expanding the Regulatorsâ Pioneer Fund in future to help regulators to keep pace with technological innovation and enable the emergence of new products, services and business models.
We will examine the case for extending the Regulatorsâ Pioneer Fund to local authorities in future, in order to help them support greater testing and trialling of innovations in their area.
We have established a Regulatorsâ Innovation Network to help foster a culture of experimentation across regulators and share best practice.
We will ask regulators to go further to evaluate the impact of their initiatives on innovation and consider whether to commence statutory reporting requirements for regulators on the impact of the economic growth duty.
We will survey innovators and regulators to identify data that could be shared to enable disruptors to enter markets and deliver better outcomes for all.
Improving access
We will consult on a digital Regulation Navigator for businesses to help them find their way through the regulatory landscape and engage with the right regulators at the right time on their proposals.
We have financed greater investment in specialist regulatory advice services for innovators through the Regulatorsâ Pioneer Fund.
We will scope and consult on measures to enhance co-ordination between regulators to ensure that innovations are guided smoothly through the system.
We will consider whether the Regulation Navigator should include functions for businesses to raise where rules or processes are inappropriately constraining innovation, so that regulators can review, clarify and potentially amend their approach.
We will invite regulators to develop metrics on the service that they provide to innovators.
We will ensure that data from specialist advice services is fed into the Regulatory Horizons Council, so that it can advise on where regulatory change or additional investment may be needed to enable innovation to thrive.
Building dialogue
We will ask the Regulatory Horizons Council to identify priorities for greater public engagement on regulation of innovation.
We will provide support, advice and share best practice with policymakers and regulators on public engagement techniques to support appropriate regulation of technological innovation.
We will encourage regulators to build public dialogue into experimentation initiatives (such as those financed through the Regulatorsâ Pioneer Fund), so that public views are considered as new products, services and business models are trialled.
Leading the world
We have established a partnership with the World Economic Forum Centre for the Fourth Industrial Revolution in San Francisco to develop regulatory approaches for new technologies.
We are working with the Organisation for Economic Co-operation and Development (OECD) to explore the regulatory challenges of the emerging digital economy.
We will improve awareness of the effects of regulation on trade among government departments and regulators so that the impacts of regulatory divergence are systematically considered.
We will seek to include ambitious chapters on good regulatory practices and regulatory co-operation in future free trade agreements that the UK negotiates following our exit from the European Union.
We will continue working alongside other nations in the international and regional standards organisations, to help secure globally accepted standards for innovators to collaborate effectively in international markets.
We are funded solely by our most generous readers and we want to keep this way. Help SILVIEW.media deliver more, better, faster, please donate here, anything helps. Thank you!
! Articles can always be subject of later editing as a way of perfecting them
One of the most maleficent characters in Trump’s menagerie is this psychopath he named as leader of Operation Warp Speed, Moncef Slaoui, former GSK and Moderna boss having a bigger body count than the Spanish Flu. Actually Kushner picked him in Trumps name, but anyway, after we wrote extensive viral exposes on his past, a team of “specialists” brushed up his online presence and then he laid low for a while. But his silence is over and his newest interviews confirm everything we’ve wrote about him and Covid-19.
For the best understanding of this article, you have to read it as a follow up to four previous pieces that are anyway essential readings:
“If you take the first Operation Warp Speed vaccine you will get an unexpected surprise: micromanaged tracking by Big Tech for up to two years, who will know more about you than you know about yourself. There is no guarantee that tracking will stop after two years.” writes Technocracy News
” It should become apparent that the military/industrial complex that is running Warp Speed is functionally merged with Big Tech like Google and Oracle. And then, there is the federal government itself that is driving the entire vaccination program”, adds TN and they’re not wrong.
Moncef Slaoui, the official head of Operation Warp Speed, told the Wall Street Journal last week that all Warp Speed vaccine recipients in the US will be monitored by âincredibly precise . . . tracking systemsâ for up to two years and that tech giants Google and Oracle would be involved.
Another high from Slaoui’s career that looks more like a bloodbath.
Last week, a rare media interview given by the Trump administrationâs âVaccine Czarâ offered a brief glimpse into the inner workings of the extremely secretive Operation Warp Speed (OWS), the Trump administrationâs âpublic-private partnershipâ for delivering a Covid-19 vaccine to 300 million Americans by next January. What was revealed should deeply unsettle all Americans.
During an interview with the Wall Street Journal published last Friday, the âcaptainâ of Operation Warp Speed, career Big Pharma executive Moncef Slaoui, confirmed that the millions of Americans who are set to receive the projectâs Covid-19 vaccine will be monitored via âincredibly precise . . . tracking systemsâ that will âensure that patients each get two doses of the same vaccine and to monitor them for adverse health effects.â Slaoui also noted that tech giants Google and Oracle have been contracted as part of this âtracking systemâ but did not specify their exact roles beyond helping to âcollect and track vaccine data.â
The day before the Wall Street Journal interview was published, the New York Times published a separate interview with Slaoui where he referred to this âtracking systemâ as a âvery active pharmacovigilance surveillance system.â During a previous interview with the journal Science in early September, Slaoui had referred to this system only as âa very active pharmacovigilance systemâ that would âmake sure that when the vaccines are introduced that weâll absolutely continue to assess their safety.â Slaoui has only recently tacked on the words âtrackingâ and âsurveillanceâ to his description of this system during his relatively rare media interviews.
While Slaoui himself was short on specifics regarding this âpharmacovigilance surveillance system,â the few official documents from Operation Warp Speed that have been publicly released offer some details about what this system may look like and how long it is expected to âtrackâ the vital signs and whereabouts of Americans who receive a Warp Speed vaccine.
This is basically what we meant by “It’s about data and vaccines” in our headline above. And 5G will follow Covid around because all this data needs carried by a medium and many antennas. Which, while doing their work, can also produce Covid-like symptoms, as a bonus benefit for the Covidiocracy orchestrators.
Stuff that no one mentions in Slaoui’s romanced biographies
The Last American Vagabond takes it from here into finer details in one of his latest posts, demonstrating we’re guinea pigs and this is how they will study us:
The Pharmacovigilantes
Two official OWS documents released in mid-September state that vaccine recipientsâexpected to include a majority of the US populationâwould be monitored for twenty-four months after the first dose of a Covid-19 vaccine is administered and that this would be done by a âpharmacovigilance system.â
In the OWS document entitled âFrom the Factory to the Frontlines,â the Department of Health and Human Services (HHS) and the Department of Defense (DOD) stated that, because Warp Speed vaccine candidates use new unlicensed vaccine production methods that âhave limited previous data on safety in humans . . . the long-term safety of these vaccines will be carefully assessed using pharmacovigilance surveillance and Phase 4 (post-licensure) clinical trials.â
It continues:
The key objective of pharmacovigilance is to determine each vaccineâs performance in real-life scenarios, to study efficacy, and to discover any infrequent and rare side effects not identified in clinical trials. OWS will also use pharmacovigilance analytics, which serves as one of the instruments for the continuous monitoring of pharmacovigilance data. Robust analytical tools will be used to leverage large amounts of data and the benefits of using such data across the value chain, including regulatory obligations.
In addition, Moncef Slaoui and OWSâs vaccine coordinator, Matt Hepburn, formerly a program manager at the Pentagonâs controversial Defense Advanced Research Projects Agency (DARPA), had previously published an article in the New England Journal of Medicine that stated that âbecause some technologies have limited previous data on safety in humans, the long-term safety of these vaccines will be carefully assessed using pharmacovigilance surveillance strategies.â
The use of pharmacovigilance on those who receive the vaccine is also mentioned in the official Warp Speed âinfographic,â which states that monitoring will be done in cooperation with the Food and Drug Administration (FDA) and the Centers for Disease Control and Protection (CDC) and will involve â24 month post-trial monitoring for adverse effects.â
In a separate part of that same document, OWS describes one of its âfour key tenetsâ as âtraceability,â which has three goals: to âconfirm which of the approved vaccines were administered regardless of location (private/public)â; to send a âreminder to return for second doseâ; and to âadminister the correct second dose.â
Regarding a Covid-19 vaccine requiring more than one dose, a CDC document associated with Operation Warp Speed states:
For most Covid-19 vaccine products, two doses of vaccine, separated by 21 or 28 days, will be needed. Because different Covid-19 vaccine products will not be interchangeable, a vaccine recipientâs second dose must be from the same manufacturer as their first dose. Second-dose reminders for vaccine recipients will be critical to ensure compliance with vaccine dosing intervals and achieve optimal vaccine effectiveness.
The CDC document also references a document published in August by the Johns Hopkins Center for Health Security, associated with the Event 201 and Dark Winter simulations, as informing its Covid-19 vaccination strategy. The Johns Hopkins paper, which counts Dark Winter co-organizer Thomas Inglesby as one of its authors, argues that existing âpassive reportingâ systems managed by the CDC and FDA should be retooled to create âan active safety surveillance system directed by the CDC that monitors all [Covid-19] vaccine recipientsâperhaps by short message service or other electronic mechanisms.â
Despite the claims in these documents that the âpharmacovigilance surveillance systemâ would intimately involve the FDA, top FDA officials stated in September that they were barred from attending OWS meetings and told reporters they could not explain the operationâs organization or when or with what frequency its leadership meets. The FDA officials did state, however, that they âare still allowed to interact with companies developing products for OWS,â STAT news reported.
In addition, the FDA has apparently âset up a firewall between the vast majority of staff and the initiative [Operation Warp Speed]â that appears to drastically limit the number of FDA officials with any knowledge of or involvement in Warp Speed. The FDAâs director of the Center for Drug Evaluation and Research, Janet Woodcock, is the only FDA official listed as having any direct involvement in OWS and appears to be personally managing this âfirewallâ at the FDA. Woodcock describes herself as a long-time advocate for the use of âbig dataâ in the evaluation of drug and vaccine safety and has been intimately involved in FDA precursors to the coming Warp Speed âpharmacovigilance surveillance systemâ known as Sentinel and PRISM, both of which are discussed later in this report.
Woodcock is currently on a temporary leave of absence from her role as the director of the Center for Drug Evaluation and Research, which allows her to focus her complete attention on overseeing aspects of Operation Warp Speed on behalf of the FDAâs Office of the Commissioner. Her temporary replacement at the FDA, Patrizia Cavazzoni, is âvery aligned with Janet and where the agency is going,â according to media reports. Cavazzoni is a former executive at Pfizer, one of the companies producing a vaccine for OWS. That vaccine is set to begin testing in children as young as 12 years old.
The extreme secrecy of Operation Warp Speed has affected not only the FDA but also the CDC, as a CDC expert panel normally involved in developing the governmentâs vaccine distribution strategies was âstonewalledâ by Matt Hepburn, OWSâs vaccine coordinator, who bluntly refused to answer several of the panelâs âpointed questionsâ about the highly secretive operation.
More Secret Contracts
While Moncef Slaoui and Warp Speed documents provide few details regarding what this âtracking systemâ would entail, Slaoui did note in his recent interview with the Wall Street Journal that tech giants Google and Oracle had been contracted to âcollect and track vaccine dataâ as part of this system. Neither Google nor Oracle, however, has announced receipt of a contract related to Operation Warp Speed, and the DOD and HHS, similarly, have yet to announce the awarding of any Warp Speed contract to either Google or Oracle. In addition, searches on the US governmentâs Federal Register and on the official website for federally awarded contracts came up empty for any contract awarded to Google or Oracle that would apply to any such âpharmacovigilanceâ system or any other aspect of Operation Warp Speed.
Given my previous reporting on the use of a nongovernment intermediary for awarding OWS contracts to vaccine companies, it seems likely that Warp Speed contracts awarded to Google and Oracle were made using a similar mechanism. In an October 6, 2020, report for The Last American Vagabond, I noted that $6 billion in Warp Speed contracts awarded to vaccine companies were made through Advanced Technology International (ATI), a government contractor that works mainly with the military and surveillance technology companies and whose parent company has strong ties to the CIA and the 2001 Dark Winter simulation. HHS, which is supposedly overseeing Operation Warp Speed, claimed to have âno recordâ of at least one of those contracts. Only one Warp Speed vaccine contract, which did not involve ATI and was awarded directly by HHSâs Biomedical Advanced Research and Development Authority, was recently obtained by KEI Online. Major parts of the contract, however, including the section on intellectual property rights, were redacted in their entirety.
If the Warp Speed contracts that have been awarded to Google and Oracle are anything like the Warp Speed contracts awarded to most of its participating vaccine companies, then those contracts grant those companies diminished federal oversight and exemptions from federal laws and regulations designed to protect taxpayer interests in the pursuit of the work stipulated in the contract. It also makes them essentially immune to Freedom of Information Act (FOIA) requests. Yet, in contrast to the unacknowledged Google and Oracle contracts, vaccine companies have publicly disclosed that they received OWS contracts, just not the terms or details of those contracts. This suggests that the Google and Oracle contracts are even more secretive.
A major conflict of interest worth noting is Googleâs ownership of YouTube, which recently banned on its massive multimedia platform all âmisinformationâ related to concerns about a future Covid-19 vaccine. With Google now formally part of Operation Warp Speed, it seems likely that any concerns about OWSâs extreme secrecy and the conflicts of interest of many of its members (particularly Moncef Slaoui and Matt Hepburn) as well as any concerns about Warp Speed vaccine safety, allocation and/or distribution may be labeled âCovid-19 vaccine misinformationâ and removed from YouTube.
From the NSA to the FDA: The New PRISM
Though the nature of this coming surveillance system for Covid-19 vaccine recipients has yet to be fully detailed by Warp Speed or the tech companies the operation has contracted, OWS documents and existing infrastructure at the FDA offer a clue as to what this system could entail.
For instance, the Warp Speed document âFrom the Factory to the Frontlinesâ notes that the pharmacovigilance system will be a new system created exclusively for OWS that will be âbuil[t] off of existing IT [information technology] infrastructureâ and will fill any âgaps with new IT solutions.â It then notes that âthe Covid-19 vaccination program requires significant enhancement of the IT that will support enhancements and data exchange that are critical for a multi-dose candidate to ensure proper administration of a potential second dose.â The document also states that all data related to the OWS vaccine distribution effort âwill be reported into a common IT infrastructure that will support analysis and reporting,â adding that this âIT infrastructure will support partners with a broad range of tools for record-keeping, data on who is being vaccinated, and reminders for second doses.â
Though some Warp Speed documents hint as to the existing IT systems that will serve as the foundation for this new tracking system, arguably the most likely candidate is the FDA-managed Sentinel Initiative, which was established in 2009 during the H1N1 Swine flu pandemic. Like Operation Warp Speed itself, Sentinel is a public-private partnership and involves the FDA, private business, and academia.
According to its website, Sentinelâs âmain goal is to improve how FDA evaluates the safety and performance of medical productsâ through big data, with an additional focus on âlearning more about potential side effects.â Media reports describe Sentinel as âan electronic surveillance system that aggregates data from electronic medical records, claims and registries that voluntarily participate and allows the agency to track the safety of marketed drugs, biologics and medical devices.â
One of Sentinelâs main proponent at the FDA is Janet Woodcock, who has aggressively worked to expand the program as director of the FDAâs Center for Drug Evaluation and Research, with a focus on Sentinelâs use in âpost-market effectiveness studies.â As previously mentioned, Woodcock is the only FDA official listed among the ninety or so âleadersâ of OWS, most of whom are part of the US military and lack any health-care or vaccine-production experience.
Woodcockâs temporary replacement at the FDA, Patrizia Cavazzoni, is also very active in efforts to expand Sentinel. STAT news reported earlier this year that Cavazzoni previously âserved on the sterling committee of I-MEDS, an FDA-industry partnership which allows drug makers to pay for use of the FDAâs real-world data system known as Sentinel to complete certain safety studies more quickly.â
Sentinel has a series of âcollaborating partnersâ that âprovide healthcare data and scientific, technical, and organizational expertiseâ to the initiative. These collaborating partners include intelligence contractor Booz Allen Hamilton, tech giant IBM, and major US health insurance companies such as Aetna and Blue Cross Blue Shield, among many others. In addition, Sentinelâs Innovation Center, which it describes as the programâs âtest bed to identify, develop, and evaluate innovative methods,â is partnered with Amazon, General Dynamics, and Microsoft. Sentinel also has a Community Building and Outreach Center, which is managed by Deloitte consulting, one of the largest consultancy firms in the world that is known for seeking to fill its ranks with former CIA officials.
The Sentinel systemâs specific surveillance program aimed at monitoring vaccine effectiveness is known as the Post-licensure Rapid Immunization Safety Monitoring Program, better known as PRISM. Sentinelâs PRISM was âdeveloped to monitor vaccine safety, but [to date] has never been used to assess vaccine effectiveness.â PRISM was initially launched alongside the Sentinel Initiative itself in 2009 âin response to the need to monitor the safety of the H1N1 influenza vaccineâ after it was licensed, marketed, and administered. Yet, as previously mentioned, PRISM has yet to be used to assess the effectiveness of any vaccine while quietly expanding for nearly a decade, which implies that the stakeholders in the Sentinel Initiative have a plan to implement this âsafety surveillance systemâ at some point.
The name PRISM may remind readers of the National Security Agency (NSA) program of the same name that became well known throughout the United States following the Edward Snowden revelations. Given this association, it is worth noting that the NSA, as well as the Department of Homeland Security (DHS), are now officially part of Operation Warp Speed and appear to be playing a role in the development of Warp Speedâs âpharmacovigilance surveillance system.â The addition of the NSA and the DHS to the initiative, of course, greatly increases the involvement of US intelligence agencies in the operation, which itself is âdominatedâ by the military and sorely lacking in civilian public health officials.
CyberScoop first reported in early September that members of the NSAâs Cybersecurity Directorate were involved in Operation Warp Speed, with their roleâas well as that of DHSâbeing framed mainly as offering âcybersecurity adviceâ to the initiative. However, the NSA and DHS are also offering âguidanceâ and âservicesâ to both the other federal agencies involved in Warp Speed as well as OWS contractors, which now include Google and Oracle.
Google is well known for its cozy relationship with the NSA, including its PRISM program, and they have also backed NSA-supported legislation that would make it easier to surveil Americans without a warrant. Similarly, Oracle is a longtime NSA contractor and also has ties to the CIA dating back to its earliest days as a company, not unlike Google. Notably, Oracle and Google remain locked in a major legal battle over copyright issues that is set to be heard by the Supreme Court in the coming weeks and is expected to have major ramifications for the tech industry.
We are funded solely by our most generous readers and we want to keep this way. Help SILVIEW.media deliver more, better, faster, please donate here, anything helps. Thank you!
! Articles can always be subject of later editing as a way of perfecting them
Companies collecting data for pubs and restaurants to help them fulfil their contact-tracing duties are harvesting confidential customer information to sell.
Legal experts have warned of a âprivacy crisisâ caused by a rise in companies exploiting QR barcodes to take names, addresses, telephone numbers and email details, before passing them on to marketers, credit companies and insurance brokers.
The âquick responseâ mobile codes have been widely adopted by the hospitality, leisure and beauty industries as an alternative to pen-and-paper visitor logs since the government ordered businesses to collect contact details to give to NHS Test and Trace if required.
Any data collected should be kept by the business for 21 days and must not be used âfor any purposes other than for NHS Test and Traceâ, according to government guidelines.
But some firms used by businesses to meet the new requirements have clauses in their terms and conditions stating they can use the information for reasons other than contact tracing, including sharing it with third parties. The privacy policy of one company used by a restaurant chain in London says it stores usersâ data for 25 years.
Gaurav Malhotra, director of Level 5, a software development company that supplies the government, said data could end up in the hands of scammers. âIf youâre suddenly getting loads of texts, your data has probably been sold on from track-and-trace systems,â he said.
One of the firms claiming to offer a privacy-compliant QR code service is Pub Track and Trace (PUBTT), an organisation based in Huddersfield charging pubs ÂŁ20 a month to keep track of visitors, who are asked to provide their name, phone number and email address.
Despite its claim to be a âsimpleâ service, its privacy policy, which users must accept, explains how personal data of people accessing its website can be used to âmake suggestions and recommendations to you about goods or services that may be of interest to youâ and shared with third parties including âservice providers or regulatory bodies providing fraud prevention services or credit/background checks.â
It may also âcollect, use, store and transferâ records of access to certain premises including âtime, ID number and CCTV imagesâ.
PUBTT, which works with pubs in England and Wales, said users agreed to its privacy policy before using the service and claimed it had not passed data to third parties. A spokesman, identified only as Adam H, said: âThe data we collect is only for use of the Test and Trace service or where a user has agreed for the venue to use their information for marketing purposes.â
Ordamo, which provides track and trace services for restaurants, states that data from website visitors is âretained for 25 yearsâ, a duration Hazel Grant, head of privacy at Fieldfisher, a law firm, said would be âvery difficult to justifyâ. Ordamo did not respond to requests for comment.
The Information Commissionerâs Office is assessing 15 companies that âprovide services to venues to collect customer logsâ.
We are funded solely by our most generous readers and we want to keep this way. Help SILVIEW.media deliver more, better, faster, please donate here, anything helps. Thank you!
! Articles can always be subject of later editing as a way of perfecting them
